Norwegian Cruise Line Q2 Adj. Loss Narrower Than Estimates - Quick Facts

Norwegian Cruise Line Holdings Ltd. (NCLH) reported Friday that its net loss for the second quarter was $717.8 million or $1.94 per share, compared to net loss of $715.2 million or $2.99 per share in the prior-year quarter.

Excluding items, adjusted loss for the quarter was $1.93 per share, compared to adjusted earnings of $2.78 per share in the prior-year quarter.

Revenue for the quarter plunged to $4.4 billion from $16.9 billion in the same quarter last year as voyages were once again suspended for the entire quarter.

On average, analysts polled by Thomson Reuters expected the company to report loss of $1.99 per share on revenues of $9.44 million for the quarter. Analysts' estimates typically exclude special items.

Looking ahead, the company said it will report a net loss for the third quarter and expects to report a net loss until the Company is able to resume regular voyages.

The Company also announced its phased relaunch plans for all 28 ships across its three brands which began with Norwegian Jade on July 25, 2021 and continues through April 1, 2022.

The first cruise to commence in the United States is scheduled on August 7, 2021 with Norwegian Encore sailing to Alaska from Seattle. The company expects to have approximately 40% of its fleet capacity operating by the end of the third quarter 2021 and approximately 75% by year-end 2021 with the full fleet expected to be back in operation by April 1, 2022.

2022 booking and pricing trends continue to be very positive driven by strong pent-up demand and the Company is experiencing robust future demand across all brands.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration is proposing a rule that will broaden the range of nonprescription or over-the counter drugs available to consumers. The rule titled, "Nonprescription Drug Product with an Additional Condition for Nonprescription Use," is intended to increase options for the development of safe and effective nonprescription drugs. The U.S. Food and Drug Administration announced that Australian organic infant formula and baby food producer, Bellamy's Organic, has agreed to send around 696,000 cans of general formula milk to the United States to meet the supply shortage. Under the FDA's enforcement discretion to source more infant formula to the U.S., the available Bellamy's Organic products include about 1.4 million pounds. The U.S. air travel industry is going through its worst crisis since the troubled travel time during the peek pandemic struggles, with thousands of flights across the country being cancelled or getting delayed. The aviation crisis, as millions are preparing to travel during the upcoming July 4th holiday weekend, is mainly attributed to the staffing issues at airlines, ...
Follow RTT